Literature DB >> 22696247

Ante-situm hepatic resection for tumors involving the confluence of hepatic veins and IVC.

Yuzo Yamamoto1.   

Abstract

BACKGROUND: For patients with bulky liver tumors that have invaded all three hepatic veins at the hepatic venous confluence to the inferior vena cava (IVC), reconstruction of at least one hepatic vein outlet to the IVC is necessary.
METHODS: To effectively treat these tumors, we performed 7 ante-situm liver resections. The ante-situm position provides surgeons with excellent visualization of the anatomical structures that should be maintained in the remnant liver. In addition, replacement of the involved IVC by a ringed expanded polytetrafluoroethylene (ePTFE) graft can be safely completed.
RESULTS: Because of the far-advanced malignancies of our 7 patients, the survival periods after surgery were limited, but the survival benefits of the procedure were not disappointing. From what has been reported in the literature, the survival periods in our patients appear to justify the employment of the procedure even when compared with survivals in patients who have less complex tumor extensions.
CONCLUSION: Because of the complexity of this procedure, a team of surgeons familiar with liver surgery and liver transplantation in a specialized hepatobiliary center is required. However, we anticipate that this procedure will be feasible and justified for selected patients in whom tumor invasion at the confluence of all three hepatic veins and the IVC is too extensive to treat with other surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22696247     DOI: 10.1007/s00534-012-0525-7

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  9 in total

Review 1.  [Vascular management in anatomical liver resection].

Authors:  S Nadalin; I Capobianco; A Königsrainer
Journal:  Chirurg       Date:  2015-02       Impact factor: 0.955

Review 2.  Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  Hepat Oncol       Date:  2013-12-20

Review 3.  Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.

Authors:  Taizo Hibi; Masahiro Shinoda; Osamu Itano; Yuko Kitagawa
Journal:  Organogenesis       Date:  2014-05-16       Impact factor: 2.500

4.  Modified ante situm liver resection without use of cold perfusion nor veno-venous bypass for treatment of hepatic lesions infiltrating the hepatocaval confluence.

Authors:  F Oldhafer; K I Ringe; K Timrott; M Kleine; O Beetz; W Ramackers; S Cammann; J Klempnauer; F W R Vondran; H Bektas
Journal:  Langenbecks Arch Surg       Date:  2018-02-22       Impact factor: 3.445

5.  Usefulness of artificial vascular graft for venous reconstruction in liver surgery.

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Hideki Yokoo; Tatsuhiko Kakisaka; Kenji Wakayama; Yosuke Tsuruga; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2014-04-23       Impact factor: 2.754

6.  Surgical management of liver diseases invading the hepatocaval confluence based on IH classification: The surgical guideline in our center.

Authors:  Wei Li; Jun Han; Zhao-Ping Wu; Hong Wu
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

Review 7.  Multiorgan resection with inferior vena cava reconstruction for hepatic alveolar echinococcosis: A case report and literature review.

Authors:  Wei Li; Hong Wu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

8.  Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein involvement: Chinese center experience.

Authors:  Zhi-Bo Xie; Ji-Chun Gu; Yi-Fan Zhang; Lie Yao; Chen Jin; Yong-Jian Jiang; Ji Li; Feng Yang; Cai-Feng Zou; De-Liang Fu
Journal:  Oncotarget       Date:  2017-09-12

9.  Long-Term Outcomes of Ante-Situm Resection and Auto-Transplantation in Conventionally Unresectable Hepatocellular Carcinoma: A Single-Center Experience.

Authors:  Qifa Ye; Cheng Zeng; Yanfeng Wang; Yingzi Ming; Qiquan Wan; Shaojun Ye; Yan Xiong; Ling Li
Journal:  Ann Transplant       Date:  2018-01-30       Impact factor: 1.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.